Literature DB >> 8425637

Evaluation and treatment of ejaculatory duct obstruction in the infertile male.

R B Meacham1, D K Hellerstein, L I Lipshultz.   

Abstract

OBJECTIVE: To evaluate the role of ejaculatory duct obstruction as a cause for male factor infertility and review the treatment of this condition.
DESIGN: A retrospective study was carried out involving male patients diagnosed as having ejaculatory duct obstruction as a contributing cause for their subfertility.
SETTING: Patients were evaluated and treated through a university-based male infertility clinic. PATIENTS, PARTICIPANTS: Patients were evaluated for the presence of ejaculatory duct obstruction if they suffered from decreased ejaculate volume, sperm density, and sperm motility but had normal physical examinations and otherwise normal laboratory evaluations.
INTERVENTIONS: Patients were treated by transurethral resection of the ejaculatory ducts. MAIN OUTCOME MEASURES: Results of semen analysis and pregnancy rates.
RESULTS: An alteration in semen quality was achieved in 79% of patients after transurethral resection. An increase in sperm density or motility was achieved in 50%, whereas 29% showed an increase in ejaculate volume only. Pregnancy rate postoperatively was 29%.
CONCLUSIONS: Ejaculatory duct obstruction as a cause of male infertility is more common than was previously recognized, especially among nonazoospermic patients. In properly selected patients, transurethral resection of the ejaculatory ducts can result in marked improvement in semen quality with subsequent pregnancy.

Entities:  

Mesh:

Year:  1993        PMID: 8425637     DOI: 10.1016/s0015-0282(16)55683-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  18 in total

1.  Ejaculatory duct dysfunction and lower urinary tract symptoms: chronic prostatitis.

Authors:  Matthew McIntyre; Harry Fisch
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

Review 2.  An update on the diagnosis and management of ejaculatory duct obstruction.

Authors:  Vaibhav Modgil; Sonpreet Rai; David J Ralph; Asif Muneer
Journal:  Nat Rev Urol       Date:  2015-12-01       Impact factor: 14.432

3.  3-month-old boy with a febrile urinary tract infection.

Authors:  Ellen Shapiro
Journal:  Rev Urol       Date:  2003

4.  The prevalence of cystic abnormalities of the prostate involving the ejaculatory ducts as detected by transrectal ultrasound.

Authors:  E D Kim; E Onel; S C Honig; L I Lipschultz
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

5.  CFTR gene mutations in men with bilateral ejaculatory-duct obstruction and anomalies of the seminal vesicles.

Authors:  D Meschede; B Dworniczak; H M Behre; S Kliesch; M Claustres; E Nieschlag; J Horst
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

6.  Mullerian duct cyst: a curable entity of male infertility. Two case reports.

Authors:  Yoshitomo Kobori; Ryo Sato; Yoshio Ashizawa; Hiroshi Yagi; Shigehiro So; Gaku Arai; Hiroshi Okada; Takashi Okuyama
Journal:  Reprod Med Biol       Date:  2010-09-28

7.  Renal agenesis, ureteral ectopia into seminal vesicle, vas deferens agenesis and hemivertebra: an incomplete form of caudal regression syndrome?

Authors:  F Aragona; L D'Urso; C Valotto; C Milani; A Calabro
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

8.  Endoscopic management of ejaculatory duct obstruction.

Authors:  A Aggour; H Mostafa; W Maged
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

9.  Transurethral resection of ejaculatory ducts in the treatment of complete ejaculatory duct obstruction.

Authors:  Talat Yurdakul; Gurhan Gokce; Ozcan Kilic; M M Piskin
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

10.  Transurethral resection of ejaculatory duct in infertile men: outcome and predictors of success.

Authors:  Ahmed El-Assmy; Hosam El-Tholoth; Rasha T Abouelkheir; Mohamed E Abou-El-Ghar
Journal:  Int Urol Nephrol       Date:  2012-07-26       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.